Your browser doesn't support javascript.
loading
Montrer: 20 | 50 | 100
Résultats 1 - 1 de 1
Filtre
Ajouter des filtres








Gamme d'année
1.
Arq. gastroenterol ; 37(4): 224-6, out.-dez. 2000.
Article Dans Anglais | LILACS | ID: lil-286404

Résumé

Abstract: The authors describe the case of a young Brazilian woman who was treated of ileocolonic Crohn's disease sparing rectum, as confirmed by colonoscopy and histopathological examination. After a 4-years course of sulfasalazine treatment, she presented with skin facial lesions in vespertilio, fever, arthralgias and high titers of anti-ANA and LE cells. A sulfasalazine-induced lupus syndrome was diagnosed, because ofter sulfasalazine withdrawal and a short course of prednisone, the clinical symptoms disappeared and the laboratory tests returned to normal. Mesalazine 3 g/day was started and patient remained well for the next 3 years, when she was again admitted with fever, weakness, arthralgias, diplopy, strabismus and hypoaesthesia in both hands and feet, microhematuria, haematic casts, hypocomplementemia and high titers of autoimmune antibodies. A diagnosis of associated systemic lupus erythematosus was made. Although a pulsotherapy with methylprednisolone was started, no improvement was noticed. A cyclophosphamide trial was tried and again no positive results occurred. The patient envolved to severe clinical manifestation of general vasculitis affecting the central and peripheral nervous system and lungs, havaing a fatal evolution after 2 weeks. Although uncommon, the association of both disease may occur, and the authors call attention to this possibiliti, making a brief review of literature.


Sujets)
Humains , Femelle , Adulte , Anti-inflammatoires non stéroïdiens/effets indésirables , Maladie de Crohn/traitement médicamenteux , Lupus érythémateux disséminé/induit chimiquement , Mésalazine/effets indésirables , Sulfasalazine/effets indésirables , Anti-inflammatoires non stéroïdiens/usage thérapeutique , Issue fatale , Mésalazine/usage thérapeutique , Sulfasalazine/usage thérapeutique
SÉLECTION CITATIONS
Détails de la recherche